Time to Buy Thermo Fisher Scientific Inc. After Today’s Option Traders Bet?

 Time to Buy Thermo Fisher Scientific Inc. After Today's Option Traders Bet?

In today’s session Thermo Fisher Scientific Inc. (TMO) registered an unusually high (1,364) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious TMO increase. With 1,364 contracts traded and 22244 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: TMO161216C00155000 closed last at: $1.25 or 8.7% up. About 412,976 shares traded hands. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 3.67% since April 5, 2016 and is uptrending. It has outperformed by 1.71% the S&P500.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Out of 13 analysts covering Thermo Fisher Scientific (NYSE:TMO), 11 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 85% are positive. $180 is the highest target while $140 is the lowest. The $156.77 average target is 3.21% above today’s ($151.89) stock price. Thermo Fisher Scientific has been the topic of 26 analyst reports since July 24, 2015 according to StockzIntelligence Inc. The firm has “Overweight” rating given on Thursday, September 22 by JP Morgan. The firm earned “Buy” rating on Tuesday, October 6 by Argus Research. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Mizuho on Friday, May 27. BTIG Research reinitiated the stock with “Buy” rating in Friday, July 22 report. The rating was maintained by Stifel Nicolaus on Monday, January 11 with “Buy”. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Overweight” rating by Barclays Capital on Tuesday, July 19. The company was initiated on Thursday, January 7 by Deutsche Bank. On Thursday, July 23 the stock rating was maintained by Mizuho with “Buy”. The stock has “Neutral” rating given by Cleveland on Friday, September 9. The rating was downgraded by Jefferies on Friday, April 29 to “Hold”.

According to Zacks Investment Research, “Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company’s four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.”

Insitutional Activity: The institutional sentiment is 0.97 in Q2 2016. Its the same as in 2016Q1. The ratio is the same, as 41 funds sold all Thermo Fisher Scientific Inc. shares owned while 373 reduced positions. only 78 funds bought stakes while 324 increased positions. They now own 337.36 million shares or 4.63% less from 353.72 million shares in 2016Q1.
Moreover, Usca Ria Ltd Liability has 0.08% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 3,084 shares. Beck Mack Oliver Limited Liability accumulated 2,715 shares or 0.01% of the stock. Strategic Advisors Ltd last reported 5,867 shares in the company. Confluence Wealth Ltd Liability Corporation, a Oregon-based fund reported 10,803 shares. Qci Asset Ny holds 88 shares or 0% of its portfolio. Nippon Life Global Investors Americas holds 32,990 shares or 0.47% of its portfolio. Scharf Invs Llc last reported 0.03% of its portfolio in the stock. Security National Bank & Trust Of So Dak accumulated 14,707 shares or 2.94% of the stock. Tekla Cap Mngmt Limited Liability holds 0.52% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 86,395 shares. Moreover, Vanguard Group Inc has 0.22% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 24.24 million shares. Papp L Roy holds 43,038 shares or 1.5% of its portfolio. Winfield Assocs, a Ohio-based fund reported 154 shares. Oakbrook Invests Limited Liability Company holds 0.36% or 44,150 shares in its portfolio. Rudman Errol M last reported 1.33% of its portfolio in the stock. Fred Alger last reported 1.77% of its portfolio in the stock.

Insider Transactions: Since May 16, 2016, the stock had 0 insider purchases, and 19 insider sales for $39.96 million net activity. Shares for $72,247 were sold by Shine Daniel P. $495,824 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by Loewald Thomas W. HOOGASIAN SETH H also sold $345,676 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares. The insider HARRIS C MARTIN sold 390 shares worth $61,359. CASPER MARC N sold $4.47M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Friday, July 1. 8,660 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $1.30M were sold by Williamson Stephen. MANZI JIM P also sold $173,961 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares.

Thermo Fisher Scientific Inc. develops, makes and sells a range of products. The company has a market cap of $59.88 billion. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It has a 30.32 P/E ratio. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

TMO Company Profile

Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, makes and sells a range of products. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Firm serves its clients through its brands, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. The Thermo Scientific brand offers clients in research, diagnostics, industrial and applied markets analytical instruments, as well as laboratory equipment, software, services, consumables and reagents.

More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Businesswire.com which released: “Thermo Fisher Scientific Wins R&D 100 Award for Thermo Scientific Vanquish …” on November 07, 2016, also Wsj.com published article titled: “Thermo Fisher Scientific Lifts Outlook”, Businesswire.com published: “Thermo Fisher Scientific Joins Cancer Moonshot Effort” on October 17, 2016. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: Finance.Yahoo.com and their article: “Thermo Fisher Scientific to Present at Baird’s 2016 Industrial Conference on …” with publication date: October 28, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment